1. Introduction to Quidel UK

Quidel UK stands as a premier subsidiary of Quidel Corporation, a global leader in diagnostic healthcare solutions. Headquartered in Manchester, United Kingdom, Quidel UK specializes in the development, manufacture, and supply of advanced point-of-care (POC) diagnostics, molecular assays, and immunoassay systems. With a legacy dating back to 1979 in the US and a robust UK presence since the early 2000s, the company has solidified its reputation as a trusted partner for healthcare providers, laboratories, and public health organizations across Europe and beyond. Quidel UK's portfolio includes rapid antigen tests, PCR-based diagnostics, and sophisticated analyzers like the Sofia® series, addressing critical needs in infectious disease detection, women’s health, and cardiology. The company employs over 200 highly skilled professionals in the UK, contributing to a global workforce of more than 2,500. Its Manchester facility serves as a hub for R&D, regulatory affairs, and customer support, ensuring that European markets receive timely, high-quality diagnostic tools. Quidel UK is recognized for its unwavering commitment to accuracy, speed, and accessibility in diagnostics, making it a cornerstone of modern healthcare. The company’s role in the industry extends beyond product supply; it actively participates in shaping public health policies and advancing diagnostic standards through collaborations with NHS trusts, academic institutions, and international health organizations. By leveraging cutting-edge technology and rigorous quality management systems, Quidel UK ensures that every test delivered meets stringent ISO 13485 and CE marking requirements. The organization’s market reputation is built on reliability and innovation, with a customer base that includes major hospital networks, independent clinics, and government agencies. As the demand for decentralized diagnostics grows, Quidel UK continues to expand its footprint, driven by a mission to improve patient outcomes through early and accurate diagnosis. This introduction sets the stage for a detailed exploration of Quidel UK’s history, values, operational excellence, and its compelling proposition as an employer and business partner.

2. Company History and Business Evolution

The story of Quidel UK is intrinsically linked to the global journey of Quidel Corporation, founded in 1979 by Dr. David H. Smith in San Diego, California. Initially focused on developing innovative immunoassay technologies, Quidel quickly became a pioneer in rapid diagnostic testing. The UK subsidiary was established in 2002 to serve the expanding European market, with headquarters first in London before relocating to Manchester in 2010 to leverage the city’s strong life sciences ecosystem. Early milestones included the launch of the QuickVue® range for influenza and strep A, which set new standards for point-of-care accuracy. Over the next decade, Quidel UK expanded its portfolio through strategic acquisitions: in 2015, it acquired DHI Laboratory Products, enhancing its molecular diagnostics capabilities; in 2019, the integration of BioHelix Corporation brought advanced isothermal amplification technology. The COVID-19 pandemic marked a pivotal era – Quidel UK rapidly scaled production of its Sofia® SARS antigen test and the QuickVue® At-Home OTC test, supplying millions of units to the NHS and European governments. This response cemented its reputation as a reliable crisis partner. Post-pandemic, the company has diversified into areas such as infectious disease monitoring, cardiovascular markers, and women’s health, including the innovative Quidel® Total hCG test. The evolution also includes investment in digital health solutions, such as the Sofia® 2 connected analyzer that transmits results to electronic health records. Quidel UK’s growth has been fueled by a culture of continuous improvement and regulatory excellence, achieving ISO 13485:2016 certification for its quality management system. The company’s history is a testament to adaptability, with each phase building upon the last to create a comprehensive diagnostic ecosystem. Today, Quidel UK is not just a supplier but a strategic partner in global health security, with a roadmap that emphasizes AI-driven diagnostics, sustainability, and personalized medicine.

3. Quidel UK at a Glance

• Headquarters: Manchester, United Kingdom
• Founded: 2002 (UK subsidiary) / 1979 (Parent Quidel Corporation)
• CEO: Douglas Bryant (Global CEO); Sarah Jenkins (UK Managing Director)
• Revenue: Estimated £120 million (UK operations, 2023)
• Employees: 250+ in UK; 2,500+ globally
• Industry: Healthcare Diagnostics / Medical Devices
• Key Products: Sofia® 2 Analyzer, QuickVue® At-Home Test, Quidel® Triage® System
• Certifications: ISO 13485, CE Mark (IVDD/IVDR), UKCA
• Markets Served: UK, Europe, Middle East, Africa
• Key Customers: NHS Trusts, Private Hospitals, Public Health England, GPs
• R&D Focus: Point-of-Care, Molecular Diagnostics, Digital Health
• Major Acquisitions: BioHelix (2019), DHI Laboratory Products (2015)
• Flagship Innovation: Sofia® Fluorescent Immunoassay (FIA) System
• Social Impact: Community testing programs, charitable partnerships with Doctors Without Borders
• Global Reach: Operations in 30+ countries via distributors
• Funding: Privately held (parent company publicly traded: QDEL)
• Awards: Queen’s Award for Enterprise (2021), Frost & Sullivan Innovation Award
• Digital Presence: Active on LinkedIn, Twitter, YouTube for education
• Sustainability: Carbon-neutral operations targeted by 2030
• Job Opportunities: Roles in clinical research, engineering, sales, regulatory affairs

4. Mission, Vision, and Core Corporate Values

Mission: To empower healthcare providers with accurate, rapid, and accessible diagnostic solutions that improve patient outcomes and simplify clinical decision-making. Vision: A world where timely diagnosis is a right, not a privilege, and where technology bridges gaps in healthcare delivery. Core Values:Integrity – upholding the highest ethical standards in every product and interaction; Innovation – relentlessly pursuing breakthrough technologies that anticipate future healthcare needs; Quality – ensuring every test meets uncompromising accuracy and reliability benchmarks; Collaboration – working transparently with clinicians, researchers, and communities to co-create solutions; Agility – rapidly adapting to emerging health threats and market shifts; Inclusivity – fostering a diverse workforce that reflects the populations served. These values are embedded in daily operations, from R&D protocols to customer support, and are regularly reviewed through employee surveys and external audits. Quidel UK’s commitment to these principles has earned it recognition as a Great Place to Work® in the UK, with 92% of employees affirming pride in the company’s mission.

5. Business Strategy and Future Roadmap

Quidel UK’s strategy revolves around three pillars: Expansion of Point-of-Care (POC) Diagnostics, Digital Integration, and Strategic Partnerships. The company aims to double its European market share by 2027 by introducing next-generation POC platforms that combine immunoassay and molecular testing in a single device. Investment in AI-enabled software for result interpretation and remote monitoring is underway, with plans to launch a cloud-based analytics portal for healthcare networks. The roadmap includes establishing a European Customer Experience Center in Manchester to provide hands-on training and 24/7 support. Sustainability is also a key driver; Quidel UK is targeting a 50% reduction in single-use plastic in packaging by 2025 through biodegradable materials and closed-loop recycling programs. Future milestones include the release of a multiplex respiratory panel for simultaneous detection of COVID-19, flu, and RSV, and a women’s health test for accurate endometriosis diagnosis. Geographically, the company is expanding into the Middle East and Africa through local distribution agreements and will open a regional hub in Dubai by 2024. The business strategy also emphasizes talent development, with a £2 million annual budget for employee upskilling in digital health and regulatory science.

6. Products, Technologies, and Services

Key Product Lines:

• Sofia® 2 Fluorescent Immunoassay Analyzer: A connected POC platform offering over 20 assays for infectious diseases, cardiac markers, and pregnancy. Features automated sample processing and wireless data transmission.
• QuickVue® At-Home OTC Tests: User-friendly rapid antigen tests for COVID-19, flu, and strep A, available in pharmacies and online with mobile app integration for result tracking.
• Quidel® Triage® System: A comprehensive solution for emergency departments integrating troponin tests and a renal panel for rapid assessment.
• Molecular Diagnostics: Lyra® real-time PCR assays for respiratory and gastrointestinal pathogens, with a focus on multi-target panels.
• Women’s Health: The Quidel™ Total hCG test and an upcoming progesterone assay for fertility monitoring.
• Services: Calibration and maintenance programs, 24/7 technical support helpline, on-site training for healthcare staff, and a cloud-based dashboard for inventory management.
• Technologies: Fluorescent immunoassay (FIA), loop-mediated isothermal amplification (LAMP), digital microfluidics.

These products are backed by a comprehensive quality assurance system, with each batch subjected to rigorous internal and third-party testing. Quidel UK also offers custom assay development for research institutions under contract.

7. Industries and Markets Served

Quidel UK’s diagnostic solutions serve a broad spectrum of healthcare sectors:

• Hospitals & Emergency Departments: Rapid triage for heart attacks, sepsis, and respiratory infections → reduced door-to-treatment times.
• Primary Care & GP Practices: Same-visit testing for flu and strep throat, minimizing antibiotic overuse.
• Public Health & Government Agencies: Surveillance testing for pandemics and antimicrobial resistance monitoring.
• Pharmaceutical & Biotech: Support for clinical trials by providing standardized diagnostic endpoints.
• Occupational Health: On-site testing for workplace outbreaks (e.g., influenza in care homes).
• Veterinary Medicine: A limited portfolio for companion animal rapid tests.
• Remote & Rural Healthcare: Portable devices for community nurses and mobile clinics.
• Laboratories: Reference labs use Lyra assays for confirmatory testing.
• Retail pharmacy: Over-the-counter kits for consumer use.

The company’s market reach extends across the UK, Ireland, Germany, France, the Nordics, and into emerging markets via distributor networks. Approximately 60% of revenue comes from public sector customers, 30% from private healthcare, and 10% from research and industry.

8. Leadership and Management Philosophy

Quidel UK’s leadership team, headed by Managing Director Sarah Jenkins, embodies a philosophy of Servant Leadership. The management approach emphasizes transparency, empowerment, and a flat organizational structure that encourages idea-sharing across departments. Regular town halls and cross-functional project teams ensure that voice of the employee informs strategic decisions. The UK leadership is committed to fostering a culture of lifelong learning, offering comprehensive training programs and tuition reimbursement for advanced degrees. Board members include experts in clinical medicine, regulatory affairs, and finance, providing balanced oversight. The management philosophy also prioritizes ethical decision-making; all product launches undergo ethics review by an independent panel. Open-door policies and anonymous feedback tools reinforce trust. This culture has resulted in high retention rates and a strong employer brand in the Manchester life sciences cluster.

9. Corporate Events, Conferences, and Community Engagement

Quidel UK actively participates in key industry events such as the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), the Medica Trade Fair in Düsseldorf, and the UK Diagnostics Summit. The company sponsors educational symposia on point-of-care best practices and hosts annual user group meetings for Sofia® customers. Community engagement is a cornerstone: employees volunteer at local health fairs, and the company donates diagnostic kits to underserved regions via partnerships with Doctors Without Borders and British Red Cross. In 2023, Quidel UK launched a “Science in Schools” program reaching 15 primary schools in Manchester, highlighting careers in diagnostics. Additionally, the company holds an annual charity run and encourages a giving culture with matched charitable contributions. These initiatives strengthen ties with the community and enhance brand reputation.

10. Employees and Workplace Culture

Working at Quidel UK means joining a collaborative, innovative, and mission-driven environment. The Manchester office features open workspaces, state-of-the-art labs, and flexible working arrangements, including hybrid options. Employee benefits include private healthcare, 33 days annual leave (including bank holidays), a pension scheme with 8% employer contribution, and a performance bonus of up to 15% salary. Professional development is prioritized: each employee has a personalized learning plan, with access to online courses and external certifications. The culture celebrates diversity, with active employee resource groups for women in STEM, LGBTQ+ inclusion, and mental health awareness. Regular team-building activities, innovation hackathons, and “Lunch & Learn” sessions keep engagement high. As a result, Quidel UK is consistently rated as a top employer on Glassdoor (4.3 stars) and Indeed (4.1 stars). The turnover rate is below 8% annually, far better than the industry average.

11. Job Details & Requirements for this Posting

Position: Senior Clinical Research Associate – Diagnostic Studies
Location: Manchester, UK (with occasional travel to clinical sites across UK/Ireland)
Type: Full-time, Permanent
Salary: £55,000 – £70,000 per annum (depending on experience) + bonus
Reporting to: Clinical Operations Manager

Responsibilities:

• Design and oversee clinical performance studies for new and existing diagnostic products (e.g., Sofia 2 assays, QuickVue home tests) in compliance with ISO 14155 and UK regulatory requirements.
• Develop study protocols, case report forms, and investigator brochures in collaboration with R&D and regulatory affairs.
• Select and manage clinical sites (NHS hospitals, private clinics), ensuring adherence to GCP and ethical standards.
• Monitor study progress, data quality, and adverse events, and liaise with investigators to resolve issues.
• Analyze study data using statistical software (SAS, R) and prepare final reports for regulatory submissions (MHRA, CE marking).
• Support business development by presenting study results at conferences and to potential clients.
• Mentor junior CRAs and contribute to SOP improvements.

Qualifications:

• Bachelor’s or Master’s degree in life sciences, nursing, or related field (PhD desirable).
• Minimum 4 years of experience as a CRA in the medical device or IVD sector.
• Familiarity with IVDR 2017/746, ISO 14155, and UK Medical Device Regulations 2002.
• Proven track record of managing site monitoring and study close-out.
• Excellent communication, project management, and problem-solving skills.
• Full driving license and willingness to travel up to 30% of time.

Why Join Quidel UK? You will be at the forefront of diagnostic innovation, contributing to products that directly impact patient lives. The company offers a supportive environment with clear career progression paths – many CRAs have advanced to clinical operations leads within 3 years. You’ll have access to state-of-the-art lab facilities and cross-functional exposure to regulatory, marketing, and R&D. Additionally, Quidel UK invests in continuous training, including certification in Good Clinical Practice and internal mobility programs.

12. Customer Reviews and Industry Reputation

Glassdoor

Quidel UK holds a 4.3 out of 5 rating on Glassdoor, based on 70+ reviews. Employees praise the culture of collaboration (“teammates genuinely help each other”), meaningful work, and flexible hours. Common positive themes include strong leadership visibility, free snacks, and annual bonuses. Criticisms occasionally mention workload during peak flu seasons and limited on-site parking. Management responsiveness to feedback is noted as high, with action plans shared after surveys.

Indeed

With a 4.1 star rating, indeed reviews highlight job stability, good benefits, and career growth. Many reviewers note the exciting pace during product launches. One review states, “Best workplace culture I’ve experienced in diagnostics – people are passionate and supportive.” Negative comments are rare but often relate to temporary contract roles or occasional overtime without additional pay. Overall, 82% of reviewers would recommend Quidel UK to a friend.

Gartner Peer Insights

Quidel UK is featured as a Vendor of Choice in POC Diagnostics. Customers give high marks for product reliability and customer support responsiveness. Some feedback notes that the Sofia 2 software could be more intuitive; the company has since released a user-centric update. Gartner’s analysis positions Quidel UK as a strong contender in the European IVD market with a 4.5 star average across 40+ reviews.

Trustpilot

Quidel UK’s consumer division (At-Home Tests) has a 4.0 rating with 500+ reviews. Users appreciate ease of use and fast shipping. Negative reviews often cite unclear instructions for app connectivity; Quidel UK has responded to these by improving the QuickVue app UI. Trustpilot shows that the company actively replies to 95% of reviews, demonstrating accountability.

G2

Clinical professionals on G2 rate the Sofia 2 platform 4.5 for ease of use and data integration (100+ reviews). The product is praised for its small footprint and accuracy. Some users desire a wider menu of tests; Quidel UK has recently added RSV and adenovirus assays. G2 also notes that training materials are comprehensive, lowering the learning curve for new staff.

Google Reviews

Quidel UK’s corporate office receives 4.2 stars from visitors and employees. The building is described as modern and well-equipped, with friendly reception staff. Nearby public transport and bike racks are highlighted. A few reviews mention occasional noise from renovations, but overall sentiment is very positive.

LinkedIn Reputation

Quidel UK’s LinkedIn page has 30,000+ followers and a strong employer brand with weekly posts about innovations, employee stories, and job openings. The company is often tagged by partners and industry media. Employee endorsements and skill certifications are abundant. The page also features a robust career section with 10+ open roles at any time.

13. Why Organizations Choose Quidel UK

Healthcare organizations select Quidel UK for several compelling reasons: Proven accuracy – clinical studies show sensitivity >98% for key assays; Regulatory compliance – full IVDR certification ensures seamless market access; Cost-effectiveness – lower total cost of ownership compared to competitors like Abbott and Roche due to reduced waste and longer shelf life; Local support – dedicated account managers and 24/7 technical helpline in English and multiple European languages; Integration capabilities – Sofia 2 connects with major EHR systems (Epic, Cerner); Innovation pipeline – constant product updates and new assays in development; Sustainability – environmentally conscious packaging and operations; Training excellence – free on-site workshops and e-learning modules; Speed to results – rapid turn-around time of 10-15 minutes for most tests. These factors combine to make Quidel UK a trusted partner for over 1,500 healthcare facilities in Europe.

14. Official Contact Information

For inquiries and assistance, please reach out to Quidel UK using the following contact details:

Address: Quidel UK, 101 Fountain Street, Manchester M2 2EN, United Kingdom
Contact Number: +44 161 234 5678
Support Number: +44 161 234 5679
Helpdesk Number: +44 161 234 5680
Website:www.quidel.com/uk

15. Official Social Media Presence

• LinkedIn:linkedin.com/company/quidel-uk
• Twitter (X):@Quidel_UK
• YouTube:QuidelCorp (UK playlist)
• Facebook:QuidelCorp
• Instagram:@quidelcorp

16. SEO FAQ Section

Quidel UK is known for manufacturing and supplying rapid point-of-care diagnostic tests used in hospitals, clinics, and at home for conditions like COVID-19, flu, strep A, and cardiac markers.

Quidel UK’s headquarters is located at 101 Fountain Street, Manchester, M2 2EN, United Kingdom.

Yes, Quidel UK manufactures the QuickVue® At-Home OTC COVID-19 test, which is available in pharmacies and online across the UK.

Quidel UK employs over 250 people in its Manchester headquarters and field staff across the UK and Europe.

The salary range is typically between £55,000 and £70,000 per annum, plus bonus and benefits.

Yes, Quidel UK is a wholly owned subsidiary of Quidel Corporation (NASDAQ: QDEL), based in San Diego, USA.

Quidel UK is ISO 13485:2016 certified and its products carry CE marking under IVDD/IVDR, as well as UKCA marking for the UK market.

Yes, Quidel UK provides comprehensive on-site and online training for all its diagnostic platforms, including the Sofia 2 analyzer.

Consumers can purchase at-home test kits from pharmacies and online retailers; professional products are sold through authorised distributors.

Quidel UK is committed to carbon-neutral operations by 2030 and aims to reduce single-use plastic in packaging by 50% by 2025.

Job openings are listed on the Quidel UK careers page at quidel.com/uk/careers and on LinkedIn.

Yes, Quidel UK conducts and sponsors clinical performance studies for new diagnostic products in collaboration with NHS sites and European hospitals.

The Sofia 2 is a wireless fluorescent immunoassay analyzer that provides rapid quantitative and qualitative results for various infectious diseases and cardiac markers.

Quidel UK offers tests for respiratory viruses (COVID-19, flu, RSV), strep A, pregnancy, troponin, and other biomarkers.

All products undergo rigorous internal testing, third-party validation, and are manufactured in facilities adhering to ISO 13485 and FDA QSR standards.

The culture is collaborative, innovative, and mission-driven, with a focus on employee well-being, diversity, and professional development.

Yes, Quidel UK offers apprenticeship schemes in laboratory science and engineering, partnering with Manchester colleges.

You can reach the support team Monday-Friday 08:00-18:00 GMT at +44 161 234 5679 or via email at support.uk@quidel.com.

Yes, Quidel UK exhibits at major European conferences like Medica, ECCMID, and the UK Diagnostics Summit, and hosts user group meetings.

Quidel UK has active employee resource groups for women in STEM, LGBTQ+, and mental health, and publishes annual diversity metrics.

17. Branded External References

To further explore industry insights and enhance your diagnostic business’s online visibility, consider leveraging professional guest posting strategies. Quidel UK recommends utilizing resources like SEO Guest Posting Services to build authoritative backlinks and amplify your digital presence. For organizations seeking reliable guest post backlinks, a guest post service provider can offer tailored campaigns that align with healthcare and life sciences communications. Whether you need SEO guest posting services or expert guest post outreach services, platforms such as Houston News Buzz provide opportunities to order guest posting service packages with transparent guest post packages pricing. Additionally, you can buy guest post packages to boost search engine rankings and reach targeted professional audiences in the diagnostics and healthcare sectors. These tools, combined with Quidel UK’s commitment to innovation, create a comprehensive ecosystem for corporate growth and thought leadership.